<SEC-DOCUMENT>0001571049-16-015674.txt : 20160531
<SEC-HEADER>0001571049-16-015674.hdr.sgml : 20160531
<ACCEPTANCE-DATETIME>20160531163038
ACCESSION NUMBER:		0001571049-16-015674
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160531
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160531
DATE AS OF CHANGE:		20160531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PHIBRO ANIMAL HEALTH CORP
		CENTRAL INDEX KEY:			0001069899
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				131840497
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36410
		FILM NUMBER:		161686262

	BUSINESS ADDRESS:	
		STREET 1:		GLENPOINTE CENTRE EAST, 3RD FLOOR
		STREET 2:		300 FRANK W. BURR BLVD., SUITE 21
		CITY:			TEANECK
		STATE:			NJ
		ZIP:			07666
		BUSINESS PHONE:		201-329-7300

	MAIL ADDRESS:	
		STREET 1:		GLENPOINTE CENTRE EAST, 3RD FLOOR
		STREET 2:		300 FRANK W. BURR BLVD., SUITE 21
		CITY:			TEANECK
		STATE:			NJ
		ZIP:			07666

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPP BROTHERS CHEMICALS INC
		DATE OF NAME CHANGE:	19980908
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t1601431_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>WASHINGTON,
DC 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>FORM 8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>PURSUANT
TO SECTION 13 OR 15(D) OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>SECURITIES
EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">Date of report
(Date of earliest event reported): May 31, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 24pt"><B>Phibro
Animal Health Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(EXACT NAME
OF REGISTRANT AS SPECIFIED IN CHARTER)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 33%; font-size: 10pt; text-align: center"><B>Delaware</B></TD>
    <TD STYLE="width: 34%; font-size: 10pt; text-align: center"><B>01-36410</B></TD>
    <TD STYLE="width: 33%; font-size: 10pt; text-align: center"><B>13-1840497</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(State
        or other jurisdiction of</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>incorporation)</B></FONT></P></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Commission File Number)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt"><B>(IRS Employer Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Glenpointe Centre East, 3rd Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>300 Frank W. Burr Boulevard, Suite 21</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Teaneck, New Jersey 07666-6712</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Address
of Principal Executive Offices, including Zip Code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(201) 329-7300</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Registrant&rsquo;s
telephone number, including area code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Former
name or former address, if changed since last report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if this
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION
OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May 31, 2016, Gerald K. Carlson, a member of the Board of Directors (the &ldquo;Board&rdquo;) of Phibro Animal Health Corporation
(the &ldquo;Company&rdquo;) and the Company&rsquo;s Chief Operating Officer, informed the Company that he is retiring from his
position as Chief Operating Officer effective July 1, 2016. Mr. Carlson has not resigned from his position on the Board of the
Company and plans to serve the remainder of his term as a director. Following his retirement, Mr. Carlson will receive the same
compensation as other non-employee directors receive for their service on the Board. We expect that Mr. Carlson and the Company
will also enter into the Company&rsquo;s standard director indemnification agreement following his retirement, which will require
the Company to indemnify Mr. Carlson to the fullest extent permitted under Delaware law against liabilities that may arise by reason
of his service on the Board and to advance expenses incurred as a result of any proceeding against him for which he could be indemnified.
Mr. Carlson&rsquo;s retirement is solely for personal reasons and is not due to any disagreement with the Company, the Company&rsquo;s
management or the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May 31, 2016, the Company also announced the appointment of Larry L. Miller as the Chief Operating Officer of the Company, effective
July 1, 2016, to fill the vacancy left by the retirement of Mr. Carlson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Miller is 52 years old and currently
serves as President, Animal Health of the Company. Mr. Miller joined the Company in that role in May 2008. Prior to joining the
Company, Mr. Miller was, from 2004 to 2008, Vice President of the Global Ruminant Business with Intervet/Schering-Plough Animal
Health, which at that time was the largest animal health ruminant business in the world. From 1998 to 2004, Mr. Miller was General
Manager for Schering-Plough&rsquo;s Australia and New Zealand Animal Health businesses, which included a diversified portfolio
of animal health and nutrition products for beef and dairy cattle, sheep, swine, poultry and companion animals. Mr. Miller held
numerous roles in sales and marketing management during his 17 years with Schering-Plough, and prior to that with American Cyanamid
Animal Health and Nutrition. He holds a B.S. degree in Animal Science from the University of Nebraska and an Executive MBA degree
from the City University of New York. Mr. Miller is a member of the Board of Trustees of the University of Nebraska Foundation
and a member of the Board of Directors of the Nebraska Innovation Campus Development Corporation of the University of Nebraska-Lincoln.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Miller&rsquo;s employment agreement
has not been amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
May 31, 2016, the Company and Mr. Carlson entered into an amendment (the &ldquo;Amendment&rdquo;) to the Employment Agreement dated
March 27, 2014 between the Company and Mr. Carlson (the &ldquo;Employment Agreement&rdquo;). Pursuant to the Amendment, Mr. Carlson
and his spouse will waive their right to participate in the Company&rsquo;s Retirement Health Care Plan upon his retirement in
exchange for a lump sum cash payment of $350,000, payable following the receipt by the Company of releases from Mr. Carlson and
his spouse. The Amendment also provides that Mr. Carlson will be entitled to a lump sum payment, payable following the receipt
by the Company of a release from Mr. Carlson, of one-third of his base salary in the event his employment with the Company is terminated
by the Company without Cause (as such term is defined in the Employment Agreement) or by Mr. Carlson for any reason, in either
case prior to December 31, 2016. This payment is in addition to certain other payments described in the Employment Agreement which
are payable to Mr. Carlson in the event his employment with the Company is terminated without Cause by the Company or by Mr. Carlson
for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 7.01 REGULATION FD DISCLOSURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 31, 2016, the Company issued a press
release announcing the retirement of Mr. Carlson and the appointment of Mr. Miller as Chief Operating Officer. A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information contained in this press
release is being furnished and shall not be deemed to be &ldquo;filed&rdquo; for purposes of Section 18 of, or otherwise regarded
as filed under, the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), nor shall it be deemed incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(d) Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 9%; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>Exhibit</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>Number</B></FONT></P></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>Description</B></FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD>99.1</TD>
    <TD>&nbsp;</TD>
    <TD>Press Release, dated May 31, 2016.&nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PHIBRO ANIMAL HEALTH CORPORATION</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Registrant</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Date: May 31, 2016</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Thomas G. Dagger</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Thomas G. Dagger</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Senior Vice President, General Counsel</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>and Corporate Secretary</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>t1601431_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><img src="exlogo.jpg"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For Immediate Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Phibro Animal Health Corporation Announces Gerald Carlson
Retirement, Larry Miller Promotion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TEANECK, N.J., May 31, 2016 (GLOBE NEWSWIRE) &ndash;
Phibro Animal Health Corporation (NASDAQ:PAHC) today announced that Gerald Carlson, Chief Operating Officer, will retire
after 14 years with Phibro, effective July 1, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jack Bendheim, Phibro&rsquo;s Chairman, President and Chief
Executive Officer commented, &ldquo;During his tenure, Jerry played a critical role in Phibro's business success. He was instrumental
to Phibro&rsquo;s strategic direction and the growth of our business, programs and people. We greatly appreciate his contributions
to shaping the organization.&rdquo; Carlson will continue as a member of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective July 1, 2016, Larry Miller will be promoted to Chief
Operating Officer. &ldquo;During his eight years as President, Animal Health, Larry has built a strong global organization. His
leadership has been key to the success of Phibro&rsquo;s sales growth worldwide. He has also been a driver of the vaccine acquisitions
which are a part of Phibro&rsquo;s strategic platform to bring animal health solutions to our customers,&rdquo; Jack Bendheim said.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Phibro Animal Health Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phibro Animal Health Corporation is a diversified global developer,
manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry,
swine, cattle, dairy and aquaculture. The company reported net sales of $749 million for the fiscal year ended June 30, 2015. For
further information, please visit www.pahc.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Richard Johnson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer, Phibro Animal Health Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 201-329-7300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">investor.relations@pahc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exlogo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ / "[ P$1  (1 0,1 ?_$ -4   $$ @,! 0
M      D !P@*!@L!! 4# @$   <! 0$               ,$!08'" (!"1
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MS!8&$]LQL\L2?2-HNS^J&WJVE>13(WG,!AY8LRAY!_F\L?02-#0L"!"P($+
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MO(PF P"&R<Q@R.'P'//%[!3G>'*I'8>0F1 Q$NB>\X0SKSK3@)=8VQ9Q[?\
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M<5!3[^[;BG;81["$!E-U T>)P\"U7**J3HX&4 _@ @.(,SJ.LYQ<Y[*:FC-
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M5 F0@"J0#\ QCKX>;"P>8UZKJ=M#C% M;: =DE+(  Z E,3O4[SW<&0T2'R
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M=)'1=LGU"I.FCI%0HE.BX;K2*B*Z1P'(2G*)1#X8(:^)'EW3@<%5<E05,$(
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MQG;^?B?IMW\FZPU:?\2[C</"?#O YW3O.?+Q^+P'I>U^)EX4\DL,LY;X(/\
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M\'/*?U<TNU&G;GW;NU-QOR>%NV[I?T],#O\ _B!M_P#V=W7-/_5'I>8?3_\
H*ZW>L_[6]9^3%O?_ ''_ .(GP.J>3_RDO-EZH:/_ $K]Z4_5_;'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
